METAXEN LLC
METAXEN LLC
Industry:
Biotechnology
Founded:
1996-01-01
Address:
South San Francisco, California, United States
Country:
United States
Status:
Active
Contact:
(650)553-8100
Similar Organizations
Element Genomics
Element Genomics is a biotechnology company that focuses on genomics and diagnostics.
More informations about "Metaxen LLC"
Metaxen LLC - Crunchbase Company Profile & Funding
Metaxen LLC is a biotechnology company focusing on molecular genetics. Metaxen LLC was acquired by Exelixis on Jul 12, 1999. Where is Metaxen LLC's headquarters? Metaxen LLC is …See details»
Sale of MetaXen Assets to Exelixis | Exelixis, Inc.
Exelixis Pharmaceuticals, Inc. and MetaXen announced that an agreement has been reached under which Exelixis will acquire the majority of the assets of MetaXen LLC, a subsidiary of UK …See details»
Metaxen LLC - Crunchbase
Metaxen LLC is a biotechnology company focusing on molecular genetics.See details»
Exelixis acquires Metaxen LLC - 1999-07-12 - Crunchbase
Jul 12, 1999 · Metaxen LLC Metaxen LLC is a biotechnology company focusing on molecular genetics. Acquiring Organization: Exelixis Exelixis works is focused on discovering, developing …See details»
Xenova Sells MetaXen Subsidiary to Exelixis - | BioWorld
Jul 13, 1999 · Xenova plc sold its U.S.-based subsidiary, MetaXen, to Exelixis Pharmaceuticals Inc. as part of a plan to significantly reduce its cash burn and focus resources on drug …See details»
METAXEN, LLC :: California (US) - OpenCorporates
Free and open company data on California (US) company METAXEN, LLC (company number 199626310067), 3910 TRUST WAY, HAYWARD, CA, 94545See details»
Sale of MetaXen Assets to Exelixis / Exelixis Will | Protext ...
Exelixis Pharmaceuticals, Inc. and MetaXen announced today that an agreement has been reached under which Exelixis will acquire the majority of assets of MetaXen LLC, a subsidiary …See details»
Metaxen LLC: Drug pipelines, Patents, Clinical trials - Synapse
Jul 12, 2023 · Explore Metaxen LLC with its drug pipeline, therapeutic area, technology platform, 3 literature.See details»
METAVISION Trademark of MetaXen LLC. Application Number: …
Apr 3, 2021 · METAVISION is a trademark and brand of MetaXen LLC, San Francisco, California 94080, UNITED STATES. This trademark was filed to EUIPO on Friday, May 21, 1999.See details»
Xenova hives off its MetaXen subsidiary for $380,000
Jul 13, 1999 · UK-based Xenova has reached agreement to sell off the majority of theassets and employees of MetaXen, its San Francisco, USA, subsidiary to US firm Exelixis for $380,000 in …See details»
BioCentury - MetaXen LLC
Sep 9, 1996 · Location: Palo Alto, Calif. Technology: Parallel approach to drug discovery.....See details»
MetaXen: Drug discovery in the fast lane - BioCentury
Sep 9, 1996 · To take advantage of that opportunity - as well as to speed its own drug discovery efforts - Xenova Group plc last week announced the formation of MetaXen LLC together with …See details»
Metaxen LLC - Updates, News, Events, Signals & Triggers
Metaxen LLC is a biotechnology company focusing on molecular genetics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log …See details»
Xenova Forms New Firm MetaXen - Pharmaceutical industry news …
Sep 15, 1996 · UK emerging pharmaceutical company Xenova is forming a new company, MetaXen, which will be located in California in the USA. The new firm will play a key role in …See details»
BioCentury - How Xenova has built its group
Jun 16, 1997 · Underneath XNVAY lies its Xenova Ltd. operating division, which conducts preclinical and therapeutic activities in the U.K., and Xenova U.K. Ltd., a holding company that …See details»
MetaXen LLC, Patent Owner, HAYWARD, CA
View MetaXen LLC's, HAYWARD, CA, patent portfolio profile on Patent Buddy. Patent Buddy is the world's most extensive database and networking website for patent attorneys, agents and …See details»
Patents Assigned to MetaXen LLC - Justia Patents Search
Apr 29, 1998 · Candidate agents that may inhibit or activate clot formation or clot lysis are added to the screening medium and suitable compounds are identified. The assay provided is …See details»
Exelixis - Funding, Financials, Valuation & Investors - Crunchbase
Exelixis has acquired 5 organizations. Their most recent acquisition was X-Ceptor Therapeutics, Inc. on Oct 19, 2004. Which types of acquisition does this organization make most frequently? …See details»
Lutz Giebel - Crunchbase Person Profile
Lutz was Founder, President and CEO of CyThera Inc., Founder and Chief Operating Officer of ExSAR and was Founder and Vice President of Research of MetaXen, LLC, now part of …See details»
Michael Ross - Senior Partner @ SV Health Investors - Crunchbase
Michael was the Founding CEO of Arris Pharmaceutical, MetaXen, ExSAR and CyThera (now Novocell). Michael was also Managing Partner in Didyma, LLC, a biotechnology management …See details»